^Yamamoto M, Kawabata S, Shimizu M (1989). "Pharmacological effects of indeloxazine, a new cerebral activator, on brain functions distinct from other cerebral metabolic enhancers". Neuropharmacology. 28 (12): 1291โ1297. doi:10.1016/0028-3908(89)90001-4. ISSN0028-3908. PMID2615913. S2CID10028363.
^Takahashi K, Yamamoto M, Suzuki M, Ozawa Y, Yamaguchi T, Andoh H, Ishikawa K (1995). "Effects of cerebral metabolic enhancers on brain function in rodents". Current Therapeutic Research. 56 (5): 478โ485. doi:10.1016/0011-393X(95)85080-5. ISSN0011-393X.
^van Reekum R, Black SE, Conn D, Clarke D (1997). "Cognition-enhancing drugs in dementia: a guide to the near future". Can J Psychiatry. 42 (Suppl 1): 35S โ50S. PMID9220128.